Меню
КартаВръзкиТемиБългарияНощта (K-TRIO)Мария Склодовска-КюриЗа ученициЗа учителиМетодологияИзненадай ме
H2020Докторантска мрежа2015–2019

ANTIVIRALS · European Training Network on Antiviral Drug Development

„Хоризонт 2020“ — Действия „Мария Склодовска-Кюри“

Период
2015-03-01 → 2019-09-30
Финансиране от ЕС
3 837 214 €
Участници
13
Схема
MSCA-ITN-ETN

Линиите свързват координатора с партньорите. За проекти отпреди 2014 г. CORDIS не винаги дава точни координати. Тези точки са на ниво град или държава.

Накратко на български

Разработването на антивирусни лекарства за борба с патогени, които не могат да бъдат предотвратени с ваксини, е основен фокус тук. Това е важно, защото много вирусни инфекции причиняват висока заболеваемост и тежки икономически загуби в целия свят.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

European Training Network on Antiviral Drug Development

Viral infections are a major cause of disease, with enormous costs in morbidity/mortality and economic losses worldwide. Since only a few viral diseases can currently be prevented by vaccination, antiviral therapy is an essential instrument to control virus infections. Antiviral therapies are available for only a few diseases, leading to a great unmet medical need for antiviral drugs to treat or prevent infections with many important human pathogens. In line with this, there is great need for experts in the field which have been trained in a multidisciplinary and intersectoral setting, with attention for both basic and applied aspects of antiviral drug development. The ANTIVIRALS consortium, consisting of 7 academic and 3 industrial leaders in the field, implemented a research, training and dissemination programme to educate these experts, to advance the field and to create a basis for further use of the results.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

Viral infections are a major cause of disease, mortality and economic losses worldwide. Antiviral therapy is an essential instrument to control virus infections. At present, however, licensed antiviral drugs have been developed only against a limited number of viruses (e.g. HIV, HCV, influenza, herpesviruses). There is a clear and unmet need for antiviral drugs to treat infections with other important human pathogens.Europe needs well-trained experts with multidisciplinary skills to advance the antiviral drug development field. However, few, if any, European universities or research institutes have the ability to deliver an intersectoral training programme that covers the broad spectrum of disciplines important for antiviral drug development.The ANTIVIRALS partnership has been established to fill this gap. It consists of six outstanding European academic partners and four industrial partners (two large R&D companies, of which one is specialized in antiviral drug discovery and development, and two SMEs), and two partner organisations (incl. one SME specialised in education). All partners are leaders in their field, ensuring state-of-the-art training possibilities, and their skills are highly complementary.ANTIVIRALS aims to introduce 15 ESRs to state-of-the-art knowledge and technology applied in antiviral drug development through both local and network-wide training activities. Individual research projects, research training workshops and intersectoral secondments will be supplemented with complementary skills courses and dissemination activities to improve career development and perspectives. The industrial partners are actively involved in the entire programme and will organize an industry-oriented conference aimed at further bridging the gap between academia and industry. Thus, ANTIVIRALS offers talented researchers a multidisciplinary and intersectoral training programme and prepares them for a future leading role in antiviral drug development in Europe.

Оригинален текст от CORDIS (на английски).

Участници

Връзки

Данни: CORDIS, © Европейски съюз